alabnii/sciclaimeval-shared-task huggingface dataset:
Styled Table

Table 6
Biomarker assessment.

Study
Process-specific classification
Methodologic quality
Clinical utility
Clinical usefulness
Biomarker validity

Beer, Rösler & Hess (1995)
Axonal damage
N
U
N
N

Caramia et al. (2004)
Demyelination,
axonal damage
N
N
N
N

Cruz-Martínez et al. (2000)
Demyelination,
axonal damage
N
Y
N
N

Facchetti et al. (1997)
Demyelination,
axonal damage
N
U
U
N

Hess et al. (1987)
Demyelination,
axonal damage
N
U
N
N

Jung et al. (2006)
Demyelination,
axonal damage
N
N
N
N

Kale et al. (2009)
Demyelination,
axonal damage
N
U
N
N

Kale, Agaoglu & Tanik (2010)
Demyelination,
axonal damage
L
U
U
L

Kandler et al. (1991)
Demyelination
H
U
H
H

Leocani et al. (2006)
Demyelination,
axonal damage, remyelination
L
U
L
L

Magistris et al. (1999)
Demyelination,
axonal damage
N
U
N
N

Mayr et al. (1991)
Demyelination
H
U
H
H

Pisa et al. (2020)
Demyelination
N
U
U
N

Ravnborg et al. (1992)
Demyelination
N
U
N
N

Schmierer et al. (2000)
Demyelination,
axonal damage
N
U
N
N

Schmierer et al. (2002)
Demyelination,
axonal damage
N
U
N
N

Tataroglu et al. (2003)
Demyelination,
excitotoxicity, axonal damage
N
U
N
N

Note: H, high; L, low; N, no; U, uncertain. See ref: ( Bielekova & Martin, 2004 ).